Understanding the costs and cost-effectiveness of TB treatment in Bangladesh

Location

Bangladesh, Bangladesh

Dates

01/01/2013 - 07/01/2015

PI

David Dowdy, MD, PhD, ScM

We have conducted an empirical costing analysis of facility-based versus community-based treatment for TB in Bangladesh and are using these results to construct models of the cost-effectiveness of novel shorter-course regimens for drug-susceptible TB.

People

Colleen Hanrahan, PhD
Faculty
Richard Chaisson, MD
Director
Vidya Mave, MD, MPH
Nicole C. Ammerman, PhD, ScM
Staff
Maunank Shah, MD, PhD
Faculty

Projects

Statins as Adjunctive, Host-Directed Therapy...

The goal of this study is to investigate the potential utility of pravastatin as an adjunctive, host-directed therapy for...

Read More

Impact of diabetes on TB treatment outcomes...

This is a study to prospectively enroll and follow TB patients co-infected with diabetes and TB patients without diabetes...

Read More

Human-centered Design and Communities of...

The goal of this project is to use local communities of practice and the emerging technique of human-centered design to improve...

Read More

A Blueprint for Success: Understanding the...

We are using a combination of statistical analysis and transmission modeling, in collaboration with the NYC Dept of Health &...

Read More

mHealth for improved TB contact investigation...

This multicenter randomized study is evaluating the implementation, effectiveness, cost-effectiveness, and population-level...

Read More